SCHEMBL12599367

SCHEMBL12599367

COc1ccc(-c2cccc(C(C)=O)c2)c(OC)c1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
PDE4D Q08499 1/20 0.52
MAPT P10636 3/20 0.50
POLB P06746 1/20 0.50
GFER P55789 1/20 0.50
TNFRSF1A P19438 1/20 0.49
FYN P06241 3/20 0.47
ERN1 O75460 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
ABCB1 P08183 1/20 0.46
CHEK1 O14757 1/20 0.45
SYK P43405 1/20 0.45
HDAC4 P56524 1/20 0.44
HDAC2 Q92769 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27586476 0.99 ALDH1A1 (0.55) ALDH1A1MEN1KMT2APDE4DMAPT
SCHEMBL1616095 0.88 STIM1 (0.54) PDE4DERN1RAB9ALMNAFNTA
SCHEMBL27736223 0.87 FYN (0.55) ALDH1A1MEN1KMT2APDE4DFYN
SCHEMBL1617752 0.87 ERN1 (0.51) ALDH1A1MEN1KMT2AMAPTERN1
SCHEMBL1617949 0.87 ERN1 (0.46) ALDH1A1MEN1KMT2APDE4DFYN
SCHEMBL14765630 0.83 ERN1 (0.43) ALDH1A1MEN1KMT2APDE4DFYN
SCHEMBL6769062 0.81 ERN1 (0.48) ALDH1A1MEN1KMT2AMAPTERN1
SCHEMBL14980439 0.80 TNFRSF1A (0.65) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL4602476 0.79 ERN1 (0.50) ALDH1A1PDE4DERN1LMNAGAA
SCHEMBL8845578 0.79 HDAC4 (0.62) ALDH1A1MEN1KMT2APDE4DPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152291-A1 NOVEL AROMATIC COMPOUNDS AND THEIR USE IN MEDICAL APPLICATIONS REVOTAR BIOPHARMACEUTICALS AG (DE) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152291-A1 NOVEL AROMATIC COMPOUNDS AND THEIR USE IN MEDICAL APPLICATIONS SELP, SELL, SELE ALDH1A1 328/4885MEN1 4309/4885KMT2A 3906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.